|
WO2006107031A1
|
|
Method of relative risk for the onset of atopic dermatitis by gene single nucleotide polymorphism analysis
|
|
AU2006201292A1
|
|
Medicament for prevention or treatment of fibrosis having chymase inhibitor as effective ingredient
|
|
AU2006201291A1
|
|
Medicament for prevention or treatment of various diseases involving an increase in eosinophils chymase inhibitor as effective ingredient
|
|
AU2006201254A1
|
|
Medicament for prevention and treatment of dermatitis having chymase inhibitor as effective ingredient
|
|
WO2006070862A1
|
|
Process for producing carbon-diminished aldose compound
|
|
CA2577201A1
|
|
A method of selecting a cardiomyocyte using intracellular mitochondria as an indicator
|
|
WO2006022301A1
|
|
Liquid preparation of physiologically active peptide
|
|
KR20060129486A
|
|
Method of proliferating pluripotent stem cell
|
|
KR20060089724A
|
|
Method of cleaving polypeptide by using ompt protease mutant
|
|
JP2006008626A
|
|
Method for producing flavone derivative, flavone derivative and medicinal composition including the same
|
|
AU2003244564A1
|
|
NF-kappa inhibitor containing as the active ingredient phenylmethyl benzoquinone
|
|
JP2006219373A
|
|
Pyridinylpyrazolopyrimidinone derivative having pde 7 inhibition
|
|
JP2006219374A
|
|
Imidazotriazinone derivative having pde 7 inhibition
|
|
JP2006176407A
|
|
New flavone derivative, method for producing the same and medicine composition containing the same
|
|
US7138489B2
|
|
Method for producing a modified peptide
|
|
JP2006151810A
|
|
Dihydrothienoquinoline derivative and cell adhesion inhibitor containing the same
|
|
AU2002327097B2
|
|
Novel glycolipid and remedial agent for autoimmune disease containing the same as active ingredient
|
|
EP1192950A1
|
|
Therapeutic drugs for dermatitis exhibiting a biphasic skin reaction containing chymase inhibitors as the active ingredient
|
|
EP1142586A1
|
|
Use of chymase inhibitors against vascular lipid deposition
|
|
EP1142573A1
|
|
Pharmaceutical compositions comprising faropenem sodium and a diamineacetate compound for improving gastrointestinal absorption
|
